Home
#Global Trends
#Vietnam
#M&A
#Regulations
#Knowledge

Category: Uncategorized

Biotech momentum builds: Seaport and Hemab target $180m Nasdaq listings

28/04/2026 Published by ViNe

April 2026 continues to be a landmark month for biotechnology IPOs as Seaport Therapeutics and Hemab Therapeutics both outline their... Read more

Tags: #Global Trends

GSK’s Tesaro unit dealt pre-trial blow in Jemperli feud with AnaptysBio

28/04/2026 Published by ViNe

GSK’s Tesaro unit has suffered a legal setback in its dispute with Jemperli developer AnaptysBio, as a Delaware court dismissed... Read more

Category: Uncategorized

Tags: #Global Trends

Ho Chi Minh City authorities impose heavy fines and suspend unlicensed clinics

28/04/2026 Published by ViNe

On the afternoon of April 28, 2026, the Ho Chi Minh City Department of Health announced a series of disciplinary... Read more

Category: Uncategorized

Tags: #Vietnam

People’s Hospital 115 acquires new premises to establish comprehensive stroke center

28/04/2026 Published by ViNe

Effective September 2026, People’s Hospital 115 will operationalize a new facility at the Hoa Hung site (formerly the District 10... Read more

Category: Uncategorized

Tags: #Vietnam

AstraZeneca secures FDA approval for Saphnelo autoinjector in lupus care

27/04/2026 Published by ViNe

The US Food and Drug Administration (FDA) has approved a subcutaneous autoinjector version of Saphnelo (anifrolumab) for adult patients suffering... Read more

Category: Uncategorized

Tags: #Global Trends

Sun Pharma to acquire Organon for $11.75bn in landmark pharmaceutical deal

27/04/2026 Published by ViNe

Sun Pharmaceutical Industries has entered into a definitive agreement to acquire Organon for an enterprise valuation of $11.75 billion in... Read more

Category: Uncategorized

Tags: #M&A

Sanofi’s MS therapy secures European endorsement following US rejection

27/04/2026 Published by ViNe

European drug regulators have issued a positive review for Sanofi’s experimental multiple sclerosis (MS) treatment. This move comes after the... Read more

Category: Uncategorized

Tags: #Global Trends

FDA approves Regeneron’s Otarmeni as the first gene therapy for genetic deafness

27/04/2026 Published by ViNe

On April 23, 2026, the US Food and Drug Administration (FDA) authorized Otarmeni (lunsotogene parvec-cwha), the first-ever gene therapy for... Read more

Category: Uncategorized

Tags: #Global Trends